Tribenzor FDA Approval History
FDA Approved: Yes (First approved July 23, 2010)
Brand name: Tribenzor
Generic name: amlodipine, hydrochlorothiazide and olmesartan
Dosage form: Tablets
Company: Daiichi Sankyo Inc.
Treatment for: High Blood Pressure
Tribenzor (amlodipine, hydrochlorothiazide and olmesartan) is a three-in-one combination product taken once-daily for the treatment of hypertension.
Development timeline for Tribenzor
| Date | Article |
|---|---|
| Jul 26, 2010 | Approval FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
